Action Exscientia - EXAI

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

4,84

Prix Achat

5,61

Prix Vente

4,55

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

4,84

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Form 15-12G - Securities registration termination [Section 12(g)]

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

EXAI - Frequently Asked Questions (FAQ)

What is the current Exscientia share price?

The current share price of Exscientia is US$ 4,84

What is the 1 year trading range for Exscientia share price?

Exscientia has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
AVGRAvinger Inc	US$ 2,05 (219,12%)	43,78M
BAOSBaosheng Media Group Holdings Ltd	US$ 3,81 (120,23%)	11,08M
CMNDClearmind Medicine Inc	US$ 2,57 (110,66%)	14,57M
TIVCTivic Health Systems Inc	US$ 0,4067 (81,24%)	37,79M
ATNF180 Life Sciences Corporation	US$ 3,29 (75,94%)	8,68M
SLGLSol Gel Technologies Ltd	US$ 0,97 (-41,21%)	499,94k
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF	US$ 14,95 (-32,72%)	1,57k
GLDDGreat Lakes Dredge and Dock Corporation	US$ 9,01 (-21,96%)	2
KALVKalVista Pharmaceuticals Inc	US$ 7,00 (-20,72%)	168
LGHLWLion Group Holding Ltd	US$ 0,006 (-20,00%)	10,02k
SVMHSRIVARU Holding Ltd	US$ 0,0334 (19,29%)	135,68M
AVGRAvinger Inc	US$ 2,05 (219,12%)	43,78M
TIVCTivic Health Systems Inc	US$ 0,4067 (81,24%)	37,79M
LAESSEALSQ Corporation	US$ 6,249 (27,53%)	16,03M
CMNDClearmind Medicine Inc	US$ 2,57 (110,66%)	14,57M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Exscientia PLC (EXAI)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

EXAI Dernières nouvelles

Form 15-12G - Securities registration termination [Section 12(g)]

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 15-12G - Securities registration termination [Section 12(g)]

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

EXAI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Exscientia PLC (EXAI) Cours

Exscientia PLC (EXAI)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

EXAI Dernières nouvelles

EXAI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR